Evaluating rectal and urogenital function after rectal surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study systematically analyzes the perioperative and postoperative development of rectal and urogenital function in patients undergoing rectal resection with total mesorectal excision. It aims to identify risk factors associated with loss of urogenital and sphincter function following the procedure. By understanding these risk factors, the study seeks to inform tailored postoperative treatment strategies that could enhance patient outcomes. The findings could significantly impact clinical management for patients with rectal cancer.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients undergoing rectal resection with total mesorectal excision

Exclusion Criteria:

* primary or secondary removal of rectal sphincter apparatus
* patients with enterostomy persisting 12 months after initial rectal resection

Where it's running

• Department of Gastrointestinal-, Thoracic and Vascular Surgery University Hospital Carl Gustav Carus Technische Universität Dresden
  Dresden, Saxony, Germany Recruiting

Study contacts

• Principal investigator: Johannes Fritzmann, Dr. — Technische Universität Dresden
• Study coordinator: Johannes Fritzmann, Dr.
• Email: johannes.fritzmann@ukdd.de
• Phone: +49 351 458 19477

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Postoperative Rectal Pain Relief With Ear Vagus Nerve Stimulation

  This study tests whether stimulating the vagus nerve through an ear-based device can reduce pain after anal or rectal surgery.

  Recruiting University Hospital, Angers · Angers, Maine et Loire · NCT07659314

• Wearable Blood Pressure Monitoring Comparison

  This study tests whether wearable devices like smartwatches can accurately measure blood pressure compared with standard cuff measurements and arterial lines in hospitalized patients.

  Recruiting Technische Universität Dresden · Dresden, Saxony and 1 other locations · NCT07719660

• Quality of life and medical care for long-term sarcoma survivors in Germany (PROSa+)

  This project will ask adults in Germany who were diagnosed with sarcoma at least five years ago to complete questionnaires and some interviews to see how cancer and its treatments affect their quality of life and medical care.

  Recruiting at 4 sites Technische Universität Dresden · Dresden, Saxony and 4 other locations · NCT07148193

• Treosulfan vs Melphalan conditioning before allogeneic transplant in AML/MDS

  In this study, adults with AML or MDS who are getting an allogeneic transplant try two different conditioning regimens (Treosulfan or Melphalan) to see which one works better and is easier to tolerate.

  Recruiting at 16 sites Phase 2 Technische Universität Dresden · Aachen and 16 other locations · NCT07025824

• Measuring metabolites in melanoma patients using advanced techniques

  This study is testing if analyzing blood and other body fluids from melanoma patients can help spot the disease earlier and track any changes in their condition.

  Recruiting Technische Universität Dresden · Dresden, Saxony · NCT06765850

• Ivosidenib maintenance after allogeneic stem cell transplant for IDH1‑mutant AML or high‑risk MDS

  This will test whether taking ivosidenib after a recent allogeneic stem cell transplant helps people with AML or high‑risk MDS who have an IDH1 mutation stay in remission longer.

  Recruiting at 14 sites Phase 2 Technische Universität Dresden · Aachen and 16 other locations · NCT06717958

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.